Fludarabine, Antithymocyte Globulin, and Very Low-Dose Busulfan for Reduced-Intensity Conditioning before Allogeneic Stem Cell Transplantation in Patients with Lymphoid Malignancies

This publication has 22 references indexed in Scilit:

• Comparison of reduced intensity and myeloablative conditioning regimens for stem cell transplantation in patients with malignancies: a meta‐analysis
  Clinical Transplantation, 2010
• Reduced-Intensity Conditioning Compared With Conventional Allogeneic Stem-Cell Transplantation in Relapsed or Refractory Hodgkin's Lymphoma: An Analysis From the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation
  Journal of Clinical Oncology, 2008
• Hematopoietic cell transplantation–specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: combined FHCRC and MDACC experiences
  Blood, 2007
• Current status of reduced intensity conditioning allogeneic stem cell transplantation for acute myeloid leukemia
  Haematologica, 2007
• Can reduced-intensity allogeneic transplantation cure older adults with AML?
  Best Practice & Research Clinical Haematology, 2007
• Nonablative allogeneic stem cell transplantation for chronic lymphocytic leukemia: impact of rituximab on immunomodulation and survival
  Experimental Hematology, 2004
• Infectious complications following allogeneic HLA-identical sibling transplantation with antithymocyte globulin-based reduced intensity preparative regimen
  Leukemia, 2003
• Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects
  Blood, 2001
• Graft-versus-leukemia reactions after bone marrow transplantation
  Blood, 1990
• Bone-Marrow Transplantation
  New England Journal of Medicine, 1975